BPC-157: what the evidence does not show

BPC-157 is a 15-amino-acid peptide based on a protein found in stomach juice. In rodent studies it speeds up healing in tendons, ligaments, muscle and gut lining, possibly by growing new blood vessels into damaged tissue.¹ Those results are why it became a gym legend.

The gap

Rats are not people. Rodent tendons heal differently, the doses are scaled guesses, and most of the work comes from one research group. Published human data is limited to a handful of small, uncontrolled reports, like a 2021 knee-pain case series with no comparison group.² There is no large randomised trial showing it works in humans, and none showing it is safe long-term.

TB-500, the peptide usually stacked with it, is a fragment of thymosin beta-4. It has animal data on wound healing and even less human data.

We would rather tell you the evidence is thin than sell you certainty we do not have.

So why sell it?

Because people are already using it, mostly from vendors who cannot tell them what is in the vial. If someone is going to run it, we would rather they get a tested product, a sensible cycle of eight weeks on and four off, and the truth about the data.

Before you use it

If you compete in any tested sport, stop here. BPC-157 and TB-500 are both on the World Anti-Doping Agency's prohibited list.³

If an injury has not improved in six weeks, see a physio or get it scanned. A torn tendon needs a diagnosis, not a peptide.